latest news releases from the newsroom
Foxby Corp. Announces Important Change in Investment Policy
NEW YORK, Oct. 30, 2003 (PRIMEZONE) -- Foxby Corp. (AMEX:FXX) today announced that shareholders had voted to approve: (1) changing the Fund's fundamental investment objective to make it a non-fundamental policy of seeking total return; (2) modifying the Fund's fundamental investment restriction on concentration; and (3) modifying certain of the Fund's other fundamental investment restrictions in order to provide for maximum investment flexibility.
Convio Enhancements Enable Robust `Solution Centers' for Online Fundraising, Advocacy, Marketing, Special Events and Web Site Management
AUSTIN, Texas, Oct. 30, 2003 (PRIMEZONE) -- Convio, Inc. today announced enhancements to its software and services offering that make it even easier for nonprofits to invest in solutions for more effective online fundraising, advocacy, marketing, special events and Web site management.
Autonomy Corporation PLC
Autonomy Corporation PLC -- Autonomy Co-Founder Acquires Autonomy Shares Through Option Exercises
CAMBRIDGE, U.K., Oct. 30, 2003 (PRIMEZONE) -- On October 27, 2003, Autonomy Corporation plc (Nasdaq: AUTN; LSE: AU.; Nasdaq Europe: AUTN), a leading provider of infrastructure software for the enterprise, announced that Richard Gaunt, Autonomy's Chief Technology Officer and co-founder, will shortly be exercising an option to purchase 4,114,240 existing Autonomy ordinary shares. Mr. Gaunt was granted these options by Dr. Michael Lynch, Autonomy's Chief Executive Officer and co-founder (3,585,825 shares), and Apax Funds Nominees Limited (528,415 shares), when Autonomy was founded in 1996. The options will lapse in December 2003 if not exercised, and this is the sole reason for the exercise. Immediately following the exercise of these options, Mr. Gaunt will sell approximately 1.66 million Autonomy ordinary shares, to cover the tax liabilities associated with the option exercise, leaving him with a holding of approximately 2.45 million Autonomy ordinary shares.
Murray, Frank & Sailer LLP
Rabin, Murray & Frank LLP Commences Class Action Against Vertex Pharmaceuticals, Inc. and Certain of its Officers and Directors Alleging Violations of Federal Securities Law -- VRTX
NEW YORK, Oct. 30, 2003 (PRIMEZONE) -- A class action complaint has been filed in the United States District Court for the District of Massachusetts , case number 03 Civ. 12085, on behalf of all persons or entities who purchased or otherwise acquired Vertex Pharmaceuticals, Inc. ("Vertex" or the "Company") securities (Nasdaq:VRTX) during the period between March 27, 2000 and September 24, 2001, both dates inclusive (the "Class Period"). The Complaint names Vertex Pharmaceuticals, Inc., Joshua S. Boger, Vicki L. Sato, Ian F. Smith, John J. Alam, M.D. Mark Murcko, Kenneth S. Boger, and Andrew S. Marks as defendants.